Last checked at 25 Jan 2021 13:31
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 22 January 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
2,449,106 | 1.90% | 600,755 | 0.47% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
272,825 | 0.21% | 445,393 | 0.35% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 6,000 | 0.00% | 6,000 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
2,727,931 | 2.12% | 1,052,148 | 0.82% | ||
|
|
|
| ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 1 | 206.3500 USD |
Purchase | 1 | 207.2000 USD |
Purchase | 7 | 207.7442 USD |
Purchase | 13 | 207.3400 USD |
Purchase | 24 | 207.4100 USD |
Purchase | 99 | 206.9896 USD |
Purchase | 100 | 207.5000 USD |
Purchase | 100 | 207.4500 USD |
Purchase | 100 | 207.5600 USD |
Purchase | 122 | 207.2600 USD |
Purchase | 128 | 207.6410 USD |
Purchase | 270 | 206.7255 USD |
Purchase | 293 | 206.7805 USD |
Purchase | 695 | 207.6790 USD |
Purchase | 893 | 206.9733 USD |
Purchase | 1,246 | 206.8834 USD |
Purchase | 1,907 | 206.4784 USD |
Purchase | 2,800 | 206.4091 USD |
Purchase | 3,284 | 206.6900 USD |
Purchase | 4,293 | 206.8167 USD |
Purchase | 8,657 | 206.5000 USD |
Purchase | 10,827 | 206.5818 USD |
Purchase | 14,904 | 206.6666 USD |
Purchase | 42,146 | 206.8125 USD |
Sale | 2 | 206.5700 USD |
Sale | 4 | 205.8300 USD |
Sale | 23 | 206.9026 USD |
Sale | 30 | 207.1700 USD |
Sale | 98 | 206.4500 USD |
Sale | 100 | 207.5600 USD |
Sale | 122 | 207.0377 USD |
Sale | 148 | 206.2986 USD |
Sale | 149 | 206.1829 USD |
Sale | 196 | 206.3484 USD |
Sale | 196 | 206.5725 USD |
Sale | 196 | 206.4450 USD |
Sale | 199 | 206.1512 USD |
Sale | 200 | 207.7300 USD |
Sale | 200 | 206.0125 USD |
Sale | 278 | 206.4299 USD |
Sale | 294 | 206.4551 USD |
Sale | 294 | 207.2459 USD |
Sale | 309 | 207.0291 USD |
Sale | 330 | 206.5035 USD |
Sale | 343 | 206.7257 USD |
Sale | 476 | 206.6609 USD |
Sale | 492 | 206.3954 USD |
Sale | 504 | 206.4906 USD |
Sale | 539 | 207.4796 USD |
Sale | 759 | 206.4269 USD |
Sale | 908 | 207.6291 USD |
Sale | 963 | 206.8422 USD |
Sale | 981 | 206.7144 USD |
Sale | 1,602 | 207.0881 USD |
Sale | 1,906 | 206.9954 USD |
Sale | 2,112 | 206.6093 USD |
Sale | 2,382 | 206.8801 USD |
Sale | 2,862 | 206.9667 USD |
Sale | 2,900 | 207.0668 USD |
Sale | 3,033 | 206.6701 USD |
Sale | 3,512 | 207.0393 USD |
Sale | 4,485 | 206.7774 USD |
Sale | 4,629 | 206.6938 USD |
Sale | 5,319 | 206.8916 USD |
Sale | 6,616 | 206.5687 USD |
Sale | 8,306 | 206.7215 USD |
Sale | 8,694 | 206.5652 USD |
Sale | 9,687 | 206.5000 USD |
Sale | 16,390 | 206.6566 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | YES |
| Date of disclosure: | 25 Jan 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
| Product name | Written or | Number of | Exercise | Type | Expiry |
| purchased | relevant securities | price | date | ||
| to which the option | |||||
| or derivative | |||||
| relates | |||||
Call Options | Purchased | 6,000 | 220.0000 | American | Jul 16, 2021 |
Put Options | Purchased | -6,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210125005464/en/
Copyright Business Wire 2021